These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer. Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090 [TBL] [Abstract][Full Text] [Related]
6. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer. Akerley W; Glantz M; Choy H Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405 [TBL] [Abstract][Full Text] [Related]
7. Phase I study of paclitaxel and epirubicin in patients with metastatic breast cancer: a preliminary report on safety. Catimel G; Spielmann M; Dieras V; Kayitalire L; Pouillart P; Guastalla JP; Soler-Michel P; Graffand N; Garet F; Dumortier A; Pellae-Cosset B; Chazard M Semin Oncol; 1996 Feb; 23(1 Suppl 1):24-7. PubMed ID: 8629032 [TBL] [Abstract][Full Text] [Related]
8. Schedule- and dose-intensified paclitaxel as weekly 1-hour infusion in pretreated solid tumors: results of a phase I/II trial. Löffler TM; Freund W; Lipke J; Hausamen TU Semin Oncol; 1996 Dec; 23(6 Suppl 16):32-4. PubMed ID: 9007118 [TBL] [Abstract][Full Text] [Related]
9. Weekly paclitaxel with epirubicin as second-line therapy of metastatic breast cancer: results of a clinical phase II study. Köhler U; Olbricht SS; Fuechsel G; Kettner E; Richter B; Ridwelski K Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-40-S17-43. PubMed ID: 9374091 [TBL] [Abstract][Full Text] [Related]
10. Phase I/II clinical trial of epirubicin and paclitaxel followed by granulocyte colony-stimulating factor in a 2-week schedule in patients with advanced or metastatic breast cancer. Ries F; Duhem C; Kleiber K; Dicato M Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-48-S17-51. PubMed ID: 9374093 [TBL] [Abstract][Full Text] [Related]
11. A phase II study of repetitive cycles of dose-intense carboplatin plus paclitaxel chemotherapy and peripheral blood stem cells in metastatic breast cancer. Ford C; Spitzer G; Reilly W; Adkins D Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-81-S17-86. PubMed ID: 9374101 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer. Wolf M; Faoro C; Goerg C; Pfab R; Havemann K; Kettner H Semin Oncol; 1996 Dec; 23(6 Suppl 16):108-12. PubMed ID: 9007135 [TBL] [Abstract][Full Text] [Related]
13. Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer. Akerley W Semin Oncol; 1996 Dec; 23(6 Suppl 16):55-8. PubMed ID: 9007123 [TBL] [Abstract][Full Text] [Related]
14. Single-agent paclitaxel for the treatment of breast cancer: an overview. Hortobagyi GN; Holmes FA Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036 [TBL] [Abstract][Full Text] [Related]
15. A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand. Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-5-S17-9. PubMed ID: 9374084 [TBL] [Abstract][Full Text] [Related]
16. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer]. Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628 [TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with upper gastrointestinal carcinomas. Ajani JA Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271 [TBL] [Abstract][Full Text] [Related]
18. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens. Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489 [TBL] [Abstract][Full Text] [Related]
19. Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer. Dieras V; Marty M; Tubiana N; Corette L; Morvan F; Serin D; Mignot L; Chazard M; Garet F; Onetto N Semin Oncol; 1995 Aug; 22(4 Suppl 8):33-9. PubMed ID: 7638640 [TBL] [Abstract][Full Text] [Related]
20. [Weekly paclitaxel therapy for metastatic breast cancer]. Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]